Select Medical (SEM) Scheduled to Post Earnings on Thursday – MarketBeat
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Select Medical (NYSE:SEM) is scheduled to be releasing its earnings data after the market closes on Thursday, February 24th. Analysts expect Select Medical to post earnings of $0.42 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.
Shares of NYSE:SEM opened at $24.17 on Thursday. The stock’s 50-day moving average is $26.42 and its 200 day moving average is $31.26. The company has a debt-to-equity ratio of 2.48, a current ratio of 1.34 and a quick ratio of 1.34. The company has a market cap of $3.24 billion, a PE ratio of 7.60, a P/E/G ratio of 0.58 and a beta of 1.29. Select Medical has a 1 year low of $21.48 and a 1 year high of $43.60.
Institutional investors and hedge funds have recently modified their holdings of the company. Deutsche Bank AG raised its holdings in Select Medical by 3.5% in the 4th quarter. Deutsche Bank AG now owns 77,080 shares of the health services provider’s stock worth $2,267,000 after acquiring an additional 2,642 shares during the last quarter. California State Teachers Retirement System raised its holdings in Select Medical by 2.4% in the 4th quarter. California State Teachers Retirement System now owns 151,541 shares of the health services provider’s stock worth $4,455,000 after acquiring an additional 3,580 shares during the last quarter. Legal & General Group Plc raised its holdings in Select Medical by 2.8% in the 4th quarter. Legal & General Group Plc now owns 317,151 shares of the health services provider’s stock worth $9,324,000 after acquiring an additional 8,537 shares during the last quarter. Millennium Management LLC raised its holdings in Select Medical by 410.6% in the 4th quarter. Millennium Management LLC now owns 787,154 shares of the health services provider’s stock worth $23,142,000 after acquiring an additional 632,984 shares during the last quarter. Finally, LPL Financial LLC raised its holdings in Select Medical by 6.8% in the 3rd quarter. LPL Financial LLC now owns 10,572 shares of the health services provider’s stock worth $382,000 after acquiring an additional 676 shares during the last quarter. 76.49% of the stock is currently owned by hedge funds and other institutional investors. (adsbygoogle = window.adsbygoogle || []).push({});
SEM has been the topic of several research reports. Royal Bank of Canada cut their price objective on Select Medical from $50.00 to $47.00 and set an “outperform” rating on the stock in a research report on Tuesday, January 18th. Deutsche Bank Aktiengesellschaft cut their price objective on Select Medical from $48.00 to $44.00 in a research report on Wednesday, January 19th. Bank of America cut their price objective on Select Medical from $40.00 to $35.00 and set a “buy” rating on the stock in a research report on Tuesday, January 18th. Finally, StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $42.50.
Select Medical Company Profile
Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility.
See Also
- Get a free copy of the StockNews.com research report on Select Medical (SEM)
- Insiders Sell SiteOne Landscape Supply, Institutions Buy It
- Matterport Shows Why the Metaverse Will Have Some Growing Pains
- Now It’s Time To Buy Roblox, Maybe
- Haverty Furniture Company Is One Comfortable Dividend-Growth Stock
- 3 Warren Buffett Stocks to Buy Now
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Select Medical, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Select Medical wasn’t on the list.
While Select Medical currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Each market day you’ll get a one-minute market summary to help you invest wisely.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.
Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.
